AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca plans $2.02b ADC manufacturing facility in Singapore
This is expected to be operational by 2029.
AstraZeneca plans $2.02b ADC manufacturing facility in Singapore
This is expected to be operational by 2029.
SG acquires AstraZeneca's Evusheld
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
AstraZeneca SG signs MOU with tech partners
The partnerships aim to improve care delivery and patient outcomes.
Commentary
Contract 'of' or 'for' Service? Or a New Legal Creature? The Singapore Platform Worker’s Bill